Constant with the single cell sequencing and the immunohistological results from previous studies,[9, 25, 27, 28, 29, 30, 31, 32] we found the presence of Olig2+ tumor OPCs in human GBMs regardless the molecular subtypes or mutations (Figures S2 and S3, Supporting Information). The gene discussed is OLIG2; the disease is neoplasm.